title: Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants.
abstract: Pretreatment 24 hr urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) levels and the Depression-type (D-type) scores (derived from a multivariate discriminant function equation based on levels of urinary catecholamines and metabolites) were examined as possible predictors of antidepressant responses to either imipramine or alprazolam. In the case of imipramine, the responders had significantly lower pretreatment urinary MHPG levels (p = 0.002) and D-type scores (p less than 0.001) than did nonresponders. In contrast, responders to the antidepressant effects of alprazolam had significantly higher pretreatment urinary MHPG levels (p less than 0.05) and D-type scores (p = 0.02) than did nonresponders. For each antidepressant treatment, D-type scores appeared to provide a better separation of responders from nonresponders than did urinary MHPG levels. For each drug, the effect size for the difference in mean log-transformed D-type scores between responders and nonresponders was greater than the effect size for the difference in mean log-transformed MHPG levels. The difference between the effect sizes was statistically significant for imipramine (p = 0.02) and tended toward significance for alprazolam using two-tailed tests. These results suggest that the D-type equation, which was initially derived to separate bipolar manic-depressive depressions from other subgroups of depressive disorders, can also be used to predict differential responses to certain antidepressant drugs in patients with unipolar depressions.
authors.affiliation: Neuropsychopharmacology Laboratory, Massachusetts Mental Health Center, Boston 02115.
authors.forename: J J
authors.initials: JJ
authors.lastname: Mooney
authors.forename: A F
authors.initials: AF
authors.lastname: Schatzberg
authors.forename: J O
authors.initials: JO
authors.lastname: Cole
authors.forename: J A
authors.initials: JA
authors.lastname: Samson
authors.forename: C
authors.initials: C
authors.lastname: Waternaux
authors.forename: B
authors.initials: B
authors.lastname: Gerson
authors.forename: K M
authors.initials: KM
authors.lastname: Pappalardo
authors.forename: J J
authors.initials: JJ
authors.lastname: Schildkraut
mesh_terms: D000328:Adult; D000525:Alprazolam / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology / Q000652:urine*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology / Q000652:urine*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use*; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000652:urine*; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D011594:Psychometrics
chemical_list: D008734:Methoxyhydroxyphenylglycol; D007099:Imipramine; D000525:Alprazolam